These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 31681597)

  • 1. Predictive Power of a Radiomic Signature Based on
    Li X; Yin G; Zhang Y; Dai D; Liu J; Chen P; Zhu L; Ma W; Xu W
    Front Oncol; 2019; 9():1062. PubMed ID: 31681597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtype classification of breast cancer using established radiomic signature models based on
    Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
    Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
    [No Abstract]   [Full Text] [Related]  

  • 3. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of radiomic signature based on 2-[
    Liu J; Zhang Z; Bian H; Zhang Y; Ma W; Wang Z; Yin G; Dai D; Chen W; Zhu L; Xu W; Zhang H; Li X
    Eur J Radiol; 2023 Oct; 167():111050. PubMed ID: 37598640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of
    Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
    Front Oncol; 2020; 10():568857. PubMed ID: 33134170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.
    Yip SS; Kim J; Coroller TP; Parmar C; Velazquez ER; Huynh E; Mak RH; Aerts HJ
    J Nucl Med; 2017 Apr; 58(4):569-576. PubMed ID: 27688480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
    de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of Conventional PET Parameters and Radiomic Features Extracted from 18F-FDG-PET/CT for Histologic Subtype Classification and Characterization of Lung Neuroendocrine Neoplasms.
    Thuillier P; Liberini V; Rampado O; Gallio E; De Santi B; Ceci F; Metovic J; Papotti M; Volante M; Molinari F; Deandreis D
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33801987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of EGFR mutation status in lung adenocarcinoma based on
    Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ
    Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?
    Ciarmiello A; Giovannini E; Tutino F; Yosifov N; Milano A; Florimonte L; Bonatto E; Bareggi C; Dellavedova L; Castello A; Aschele C; Castellani M; Giovacchini G
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731142
    [No Abstract]   [Full Text] [Related]  

  • 15. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
    Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J
    Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
    Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
    Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics based on
    Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
    Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
    Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
    Front Oncol; 2021; 11():603882. PubMed ID: 33738250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.